CD34 and neoplasm: There are no robust syngeneic or transgenic mouse models of Ewing sarcoma (17), so for this study, we developed a humanized mouse model of Ewing sarcoma utilizing a hu-CD34+ model to be able to ask specific questions about how radiotherapy and TGFβ inhibition affect the tumor immune response.